The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 22, 2019

Filed:

Apr. 23, 2018
Applicant:

Surmodics, Inc., Eden Prairie, MN (US);

Inventor:

Joram Slager, Saint Louis Park, MN (US);

Assignee:

Surmodics, Inc., Eden Prairie, MN (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/435 (2006.01); A61K 31/436 (2006.01); A61K 9/00 (2006.01); A61K 9/107 (2006.01); A61K 9/19 (2006.01); A61K 9/51 (2006.01); A61L 29/08 (2006.01); A61L 29/16 (2006.01); A61K 9/14 (2006.01); A61K 9/16 (2006.01);
U.S. Cl.
CPC ...
A61K 31/436 (2013.01); A61K 9/0019 (2013.01); A61K 9/1075 (2013.01); A61K 9/145 (2013.01); A61K 9/1688 (2013.01); A61K 9/19 (2013.01); A61K 9/5123 (2013.01); A61K 9/5138 (2013.01); A61K 9/5146 (2013.01); A61L 29/085 (2013.01); A61L 29/16 (2013.01); Y02A 50/402 (2018.01); Y02A 50/478 (2018.01); Y10T 428/2982 (2015.01);
Abstract

The disclosure provides macrolide particulates including a macrolide therapeutic agent such as rapamycin at high concentration in the particulate. In one method the particulates are made by adding a composition containing an polyoxyethylene sorbitan n-acyl ester, poly(ethyleneimine), or alkylated quaternary ammonium salt to a composition including macrolide dissolved in an alcohol such as ethanol. In another method the particulates are made by adding a non-solvent composition to a composition including macrolide and an alkyl-substituted chromanol dissolved in an alcohol such as ethanol. The formed macrolide particulates have one or more desirable properties including sizes in the range of 0.1 μm to 10 μm, spherical or near spherical shapes, low polydispersity, and/or stability. The macrolide particulates can be used for therapeutic compositions, or in association with an implantable or insertable medical device, such as associated with a polymeric coating on a device.


Find Patent Forward Citations

Loading…